As of Thursday close, Teladoc Health Inc.’s (NYSE:TDOC) stock was up $0.26, moving up 1.14 percent to $23.14. The average number of shares traded per day over the past five days has been 4,273,300 shares. 1 time new highs have been achieved over the past 5 days, with a -$1.19 fall in that time frame. In the last twenty days, the average volume was 7,748,035, while in the previous 50 days, it was 5,858,598.
Since last month, TDOC stock retreated -8.39%. Shares of the company fell to $22.63 on 08/17/23, the lowest level in the past month. A 52-week high of $38.47 was reached on 02/02/23 after having rallying from a 52-week low of $21.60. Since the beginning of this year, TDOC’s stock price has dropped by -2.16% or -$0.51, and marked a new high 8 times. However, the stock has declined by -39.85% since its 52-week high.
TDOC stock investors should be aware that Teladoc Health Inc. (TDOC) stock had its last reported insider trading activity 16 days ago on Aug 02. Waters Michael Willem, the CHIEF OPERATING OFFICER of the company, disposed of 19,340 shares for $27.03 on Aug 02. It resulted in a $522,741 divestment by the insider. Raman-Tangella Vidya sold 5,215 shares at an average price of $27.03 on Aug 02. The insider now owns 30,649 shares following the transaction. On Jul 27, CHIEF EXECUTIVE OFFICER GOREVIC JASON N sold 10,000 shares at $30.03 apiece. The transaction was valued at $300,303.
Valuation Metrics
The stock’s beta is 1.12. Besides these, the trailing price-to-sales (P/S) ratio of 1.53, the price-to-book (PB) ratio of 1.66, and the price-to-cash flow ratio of 60.69 may also be considered.
Financial Health
In the three months ended June 29, Teladoc Health Inc.’s quick ratio stood at 3.40, while its current ratio was 3.40, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 0.67, and the total debt-to-equity ratio was 0.67. On the profitability front, the trailing twelve-month gross margin is 70.20% percent. Based on annual data, TDOC earned $1.66 billion in gross profit and brought in $2.41 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -353.40%. Return on equity (ROE) for the past 12 months was -124.10%.
According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. TDOC’s revenue rose 9.2% to $629.24 million during the quarter, while net income inched up to $652.41 million. While analysts expected Teladoc Health Inc. to report -$0.41 quarterly earnings, the actual figure was -$0.4 per share, beating the consensus estimate by 2.40%. During the quarter, the company generated $8.03 million in EBITDA. The liabilities of Teladoc Health Inc. were 2.02 billion at the end of its most recent quarter ended June 29, and its total debt was $1.59 billion. The value of shareholders’ equity is $164.95 million.
Technical Picture
This quick technical analysis looks at Teladoc Health Inc.’s (TDOC) price momentum. With a historical volatility rate of 22.44%, the RSI 9-day stood at 34.62% on 17 August.
With respect to its five-day moving average, the current Teladoc Health Inc. price is down by -4.89% percent or -$1.19. At present, TDOC shares trade -2.03% below its 20-day simple moving average and -7.66% percent below its 100-day simple moving average. However, the stock is currently trading approximately -8.83% below its SMA50 and -21.69% below its SMA200.
Stochastic coefficient K was 4.20% and Stochastic coefficient D was 6.92%, while ATR was 1.14. Given the Stochastic reading of 6.78% for the 14-day period, the RSI (14) reading has been calculated as 40.24%. As of today, the MACD Oscillator reading stands at -1.10, while the 14-day reading stands at -2.15.
Analyst Ratings
Stephens launched its rating on Teladoc Health Inc. (NYSE: TDOC) to an Equal-weight in a note to investors on April 12, 2023. Teladoc Health Inc. (TDOC) has been rated Hold by analysts. According to 0 brokerage firms, TDOC is a sell, and 23 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Teladoc Health Inc. stock as buy, with 5 recommending it as overweight.
With a median target price of $29.00, the current consensus forecast for the stock is $25.00 – $40.00. Based on these forecasts, analysts predict Teladoc Health Inc. (TDOC) will achieve an average price target of $29.73.
